Diabetes patients sue 3 drug companies over alleged fraudulent insulin pricing
By Kelly Gooch
Eleven diabetes patients are suing several drug companies for alleged collusion on insulin pricing, reports The Washington Post.
The lawsuit was filed Monday in U.S. District Court in Massachusetts against Indianapolis-based Eli Lilly, French pharmaceutical company Sanofi and Danish drugmaker Novo Nordisk. The suit claims the companies systematically increased insulin list prices for years in an alleged
Read more…